Behnam Sadeghi

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: MEDICAL ONCOLOGY. 2023;40(6):168

Pentoxifylline changes the balance of immune cell population in breast tumor-infiltrating lymphocytes.

Kazemi MH; Shokrollahi Barough M; Momeni-Varposhti Z; Ghanavatinejad A; Zarehzadeh Mehrabadi A; Sadeghi B; Falak R
Article: CYTOTHERAPY. 2023;25(1):68-75

Immunomodulation by placenta-derived decidua stromal cells. Role of histocompatibility, accessory cells and freeze-thawing.

Sadeghi B; Witkamp M; Schefberger D; Arbman A; Ringdén O
Article: IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY. 2022;21(2):167-177

Decrease of Tumor-infiltrating Regulatory T Cells Using Pentoxifylline: An Ex Vivo Analysis in Triple-negative Breast Cancer Mouse Model.

Kazemi MH; Shokrollahi Barough M; Ghanavatinejad A; Momeni-Varposhti Z; Khorrami S; Sadeghi B; Falak R
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:963445

Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review.

Sadeghi B; Ringdén O; Gustafsson B; Castegren M
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2021;25(22):10554-10564

Conquering the cytokine storm in COVID-19-induced ARDS using placenta-derived decidua stromal cells.

Sadeghi B; Roshandel E; Pirsalehi A; Kazemi S; Sankanian G; Majidi M; Salimi M; Aghdami N; Sadrosadat H; Samadi Kochaksaraei S; Alaeddini F; Ringden O; Hajifathali A
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2021;113(5):712-722

Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care.

Ringdén O; Remberger M; Törlén J; Finnbogadottir S; Svahn B-M; Sadeghi B
Article: INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 2020;153:317-326

Silk fibroin/sericin 3D sponges: The effect of sericin on structural and biological properties of fibroin.

Siavashani AZ; Mohammadi J; Rottmar M; Senturk B; Nourmohammadi J; Sadeghi B; Huber L; Maniura-Weber K
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2020;111(4):591-594

Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells.

Sadeghi B; Ersmark B; Moretti G; Mattsson J; Ringdén O
Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2020;78:106042

The kidney injury caused by the onset of acute graft-versus-host disease is associated with down-regulation of αKlotho.

Amin R; He R; Gupta D; Zheng W; Burmakin M; Mohammad DK; DePierre JW; Sadeghi B; Olauson H; Wernerson A; El-Andaloussi S; Hassan M; Abedi-Valugerdi M
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:567210

Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.

Ringdén O; Gustafsson B; Sadeghi B
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1975-1983

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Ringdén O; Boumendil A; Labopin M; Canaani J; Beelen D; Ehninger G; Niederwieser D; Finke J; Stelljes M; Gerbitz A; Ganser A; Kröger N; Kantz L; Brecht A; Savani B; Sadeghi B; Mohty M; Nagler A
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1965-1969

Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease.

Sadeghi B; Remberger M; Gustafsson B; Winiarski J; Moretti G; Khoein B; Klingspor L; Westgren M; Mattsson J; Ringdén O
Article: TRANSPLANTATION. 2019;103(6):1247-1252

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor.

Ringden O; Remberger M; Gustafsson B; Moretti G; Mattsson J; Winiarski J; Sadeghi B
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:2685

Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells.

Sadeghi B; Moretti G; Arnberg F; Samén E; Kohein B; Catar R; Kamhieh-Milz J; Geissler S; Moll G; Holmin S; Ringdén O
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2018;107(4):478-485

Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.

Ringdén O; Sadeghi B; Moretti G; Finnbogadottir S; Eriksson B; Mattsson J; Svahn B-M; Remberger M
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2018;7(4):325-331

Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B
Article: JOURNAL OF INTERNAL MEDICINE. 2018;283(2):166-177

What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?

Ringdén O; Labopin M; Sadeghi B; Mailhol A; Beelen D; Fløisand Y; Ghavamzadeh A; Finke J; Ehninger G; Volin L; Socié G; Kröger N; Stuhler G; Ganser A; Schmid C; Giebel S; Mohty M; Nagler A
Article: ACTA HAEMATOLOGICA. 2018;139(2):106-114

Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation.

Aronsson-Kurttila W; Baygan A; Moretti G; Remberger M; Khoein B; Moll G; Sadeghi B; Ringdén O
Article: PEDIATRIC TRANSPLANTATION. 2017;21(5)

Successful treatment with placenta-derived decidual stromal cells in a pediatric patient with life-threatening acute gastrointestinal graft-versus-host disease.

Gustafsson B; Frisk P; Szakos A; Sadeghi B; Ringdén O; Frost B-M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2017;176(3):431-439

Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT.

Ringdén O; Labopin M; Schmid C; Sadeghi B; Polge E; Tischer J; Ganser A; Michallet M; Kanz L; Schwerdtfeger R; Nagler A; Mohty M; Acute Leukaemia Working Party of the EBMT
Article: FRONTIERS IN IMMUNOLOGY. 2017;8:795

Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis.

Baygan A; Aronsson-Kurttila W; Moretti G; Tibert B; Dahllöf G; Klingspor L; Gustafsson B; Khoein B; Moll G; Hausmann C; Svahn B-M; Westgren M; Remberger M; Sadeghi B; Ringden O
Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2016;40:41-49

Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice.

Abedi-Valugerdi M; Wolfsberger J; Pillai PR; Zheng W; Sadeghi B; Zhao Y; Hassan M
Article: CYTOTHERAPY. 2015;17(12):1732-1745

Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo.

Sadeghi B; Heshmati Y; Khoein B; Kaipe H; Uzunel M; Walfridsson J; Ringdén O
Article: STEM CELLS AND DEVELOPMENT. 2015;24(19):2269-2279

Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua.

Moll G; Ignatowicz L; Catar R; Luecht C; Sadeghi B; Hamad O; Jungebluth P; Dragun D; Schmidtchen A; Ringdén O
Article: STEM CELLS AND DEVELOPMENT. 2015;24(12):1471-1482

Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patients.

Kaipe H; Carlson L-M; Erkers T; Nava S; Molldén P; Gustafsson B; Qian H; Li X; Hashimoto T; Sadeghi B; Alheim M; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2013;48(6):843-848

Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion.

Al Hashmi S; Sadeghi B; Hassan Z; Abedi-Valugerdi M; Lindskog M; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2013;48(2):284-293

Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target?

Sadeghi B; Al-Chaqmaqchi H; Al-Hashmi S; Brodin D; Hassan Z; Abedi-Valugerdi M; Moshfegh A; Hassan M
Article: PLOS ONE. 2013;8(4):e60367

The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host disease.

Al-Chaqmaqchi H; Sadeghi B; Abedi-Valugerdi M; Al-Hashmi S; Fares M; Kuiper R; Lundahl J; Hassan M; Moshfegh A
Article: PLOS ONE. 2012;7(1):e30897

Busulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthase.

Al-Hashmi S; Boels PJM; Zadjali F; Sadeghi B; Sällström J; Hultenby K; Hassan Z; Arner A; Hassan M
Article: NATURE MEDICINE. 2011;17(12):1636-1640

Inhibition of proteasome deubiquitinating activity as a new cancer therapy.

D'Arcy P; Brnjic S; Olofsson MH; Fryknäs M; Lindsten K; De Cesare M; Perego P; Sadeghi B; Hassan M; Larsson R; Linder S
Article: INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. 2011;4(6):596-605

Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen.

Al-Hashmi S; Hassan Z; Sadeghi B; Rozell B; Hassan M
Article: CLINICAL AND DEVELOPMENTAL IMMUNOLOGY. 2010;2010:142943-13

Expansion and activation kinetics of immune cells during early phase of GVHD in mouse model based on chemotherapy conditioning.

Sadeghi B; Al-Hashmi S; Hassan Z; Rozell B; Concha H; Lundmark C; Grönvik K-O; Abedi-Valugerdi M; Hassan M
Article: DARU-JOURNAL OF PHARMACEUTICAL SCIENCES. 2009;17(3):148-156

Preclinical and phase 1 clinical safety of Setarud (IMOD™), a novel immunomodulator

Khairandish P; Mohraz M; Farzamfar B; Abdollahi M; Shahhosseiny MH; Madani H; Sadeghi B; Heshmat R; Gharibdoust F; Khorram-Khorshid HR
Article: BONE MARROW TRANSPLANTATION. 2008;42(12):807-818

GVHD after chemotherapy conditioning in allogeneic transplanted mice.

Sadeghi B; Aghdami N; Hassan Z; Forouzanfar M; Rozell B; Abedi-Valugerdi M; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2008;41(10):895-904

The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model.

Sadeghi B; Jansson M; Hassan Z; Mints M; Hägglund H; Abedi-Valugerdi M; Hassan M
Article: HUMAN REPRODUCTION. 2008;23(1):139-143

Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient.

Mints M; Jansson M; Sadeghi B; Westgren M; Uzunel M; Hassan M; Palmblad J
Article: DARU-JOURNAL OF PHARMACEUTICAL SCIENCES. 2008;16:31-34

Effect of ANGIPARS™, a new herbal drug on diabetic foot ulcer:: A phase 2 clinical study

Masoompour SM; Bagheri MH; Borhani HA; Novitsky YA; Sadeghi B; Gharibdoust F; Larijani B; Ranjbar OG
Article: DARU-JOURNAL OF PHARMACEUTICAL SCIENCES. 2008;16(4):223-228

Studies on potential mutagenic and genotoxic activity of Setarud

Khorshid KHR; Novitsky YA; Abdollahi M; Shahhosseiny MH; Sadeghi B; Madani H; Rahimi R; Farzamfar B
Article: DARU-JOURNAL OF PHARMACEUTICAL SCIENCES. 2008;16:20-24

In vivo and in vitro genotoxicity studies of Semelil (ANGIPARS™)

Khorram KHR; Sadeghi B; Heshmat R; Abdollahi M; Salari P; Farzamfar B; Madani SH
Article: ACTA PAEDIATRICA. 2003;92(12):1394-1397

Effects of passive smoking on common respiratory symptoms in young children.

Shiva F; Nasiri M; Sadeghi B; Padyab M
Article: CLINICAL BIOCHEMISTRY. 2001;34(4):309-315

Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease.

Haidari M; Javadi E; Sadeghi B; Hajilooi M; Ghanbili J
Visa fler

Alla övriga publikationer

Other: CLINICAL CASE REPORTS. 2022;10(5):e05851

Decidual stromal cell therapy for generalized lymphadenopathy as a special clinical manifestation of COVID-19 infection: A case report.

Pirsalehi A; Soleimani M; Hajifathali A; Sadeghi B; Farhadihosseinabadi B; Akhlaghi SS; Roshandel E
Review: FRONTIERS IN IMMUNOLOGY. 2022;13:839844

Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.

Ringdén O; Moll G; Gustafsson B; Sadeghi B
Corrigendum: BIOMATERIALS SCIENCE. 2020;8(1):517

Correction: Silk based scaffolds with immunomodulatory capacity: anti-inflammatory effects of nicotinic acid.

Siavashani AZ; Mohammadi J; Maniura-Weber K; Senturk B; Nourmohammadi J; Sadeghi B; Huber L; Rottmar M
Published paper: BIOMATERIALS SCIENCE. 2019;8(1):148-162

Silk based scaffolds with immunomodulatory capacity: anti-inflammatory effects of nicotinic acid.

Zakeri Siavashani A; Mohammadi J; Maniura-Weber K; Senturk B; Nourmohammadi J; Sadeghi B; Huber L; Rottmar M
Review: BONE MARROW TRANSPLANTATION. 2014;49(6):737-743

Stromal cells-are they really useful for GVHD?

Kaipe H; Erkers T; Sadeghi B; Ringdén O
Book chapter: 2013;p. 101-124

6 Mesenchymal stem cells for clinical/therapeutic interventions of graft-versus-host disease

Ringdén O; Sadeghi B
Book chapter: 2013;p. 125-142

7 Mesenchymal stem cells for graft-versus-host disease in experimental animal models

Sadeghi B; Ringdén O
Editorial comment: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(11):1615-1617

Is graft-versus-leukemia more effective using reduced-intensity conditioning compared with myeloablative conditioning?

Ringdén O; Sadeghi B

Anställningar

Senior Forskare, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2022-

Examina och utbildning

Medicine Doktorsexamen, Institutionen för laboratoriemedicin, Karolinska Institutet, 2009

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI